Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: A system, device and method for sterilizing or decontaminating an object that includes a sealable sterilizing chamber (12) and a sterilant gas-generating composition (24) that preferably generates NO or a mixture of NO and NO2. The preferred sterilant gas-generating composition (24) includes a carbon-based diazeniumdiolate compound and a powdered acid.

Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present disclosure relates to a system and method for determining amounts of carbon dioxide, other greenhouse gas (GHG), and/or toxic gaseous emissions from a mobile or stationary emissions source such as automobiles having an internal combustion engine, fossil-fuel or other hydrocarbon-burning facilities, or the like. The system and method may calculate the amount of GHG emissions by measuring fuel consumption and converting to GHG emissions based on the known carbon content for the fuel. The system and method disclosed further include the generation and distribution of reports related to fuel consumption and/or GHG emissions data. The system may be used to monitor and track fuel saving measures, enforce compliance to regulatory limits, carbon taxes, or cap-and-trade programs, and the like.

Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: A system, device and method for sterilizing or decontaminating an object that includes a sealable sterilizing chamber (12) and a sterilant gas-generating composition (24) that preferably generates NO or a mixture of NO and NO2. The preferred sterilant gas-generating composition (24) includes a carbon-based diazeniumdiolate compound and a powdered acid.

Abstract: Whenever a resource being modeled is accessed, an indication about the access is stored in a number of memory locations of a corresponding number of applications that are interested in monitoring the resource. The memory locations (also called “monitoring memory locations”) are individually identified for each application when allocating a location in main memory. At this time, a pointer to the monitoring memory location is supplied to the application and also added to a group of pointers of locations to be updated when accessing the resource. In addition, in certain embodiments, a bit is allocated within a bitmap for each monitoring memory location for any given application. Such a bit is set at the time of updating the corresponding monitoring memory location and cleared when the application reads the monitoring memory location. Just checking the bitmap as a whole can inform an application if there is any change in any monitoring memory locations of that application.

Abstract: An easily assembled provisional orthopaedic implant having first and second components. The first component may include a stem which can be inserted into an intramedullary canal and may be a femoral component of a knee joint prosthesis. The second component has a body and a sliding retention member. The retention member can be manually engaged with a groove on the stem of the first component to lock the two components together. The second component may form of an intercondylar box and have a projecting tab engageable with a recess on the femoral component to properly orient the two components when they are placed in registry with each other.

Abstract: An easily assembled provisional orthopaedic implant having first and second components. The first component may include a stem which can be inserted into an intermedulary canal and may be a femoral component of a knee joint prosthesis. The second component has a body and a sliding retention member. The retention member can be manually engaged with a groove on the stem of the first component to lock the two components together. The second component may form of an intercondylar box and have a projecting tab engageable with a recess on the femoral component to properly orient the two components when they are placed in registry with each other.

Abstract: The present invention provides solid supports (e.g., glass) and polymer hydrogels (particularly polymer hydrogel arrays present on a solid support) comprising one or more reactive sites for the attachment of biomolecules, as well as biomolecules comprising one or more reactive sites for attachment to solid supports and polymer hydrogels. The invention further provides novel compositions and methods for the preparation of biomolecules, solid supports, and polymer hydrogels comprising reactive sites. The invention also provides for preparation of crosslinked solid supports, polymer hydrogels, and hydrogel arrays, wherein one or more biomolecules is attached by means of the reactive sites in a photocycloaddition reaction. Advantageously, according to the invention, crosslinking of the hydrogel and attachment of biomolecules can be done in a single step.

Abstract: The present invention provides solid supports (e.g., glass) and polymer hydrogels (particularly polymer hydrogel arrays present on a solid support) comprising one or more reactive sites for the attachment of biomolecules, as well as biomolecules comprising one or more reactive sites for attachment to solid supports and polymer hydrogels. The invention further provides novel compositions and methods for the preparation of biomolecules, solid supports, and polymer hydrogels comprising reactive sites. The invention also provides for preparation of crosslinked solid supports, polymer hydrogels, and hydrogel arrays, wherein one or more biomolecules is attached by means of the reactive sites in a photocycloaddition reaction. Advantageously, according to the invention, crosslinking of the hydrogel and attachment of biomolecules can be done in a single step.

Abstract: The present invention provides solid supports (e.g., glass) and polymer hydrogels (particularly polymer hydrogel arrays present on a solid support) comprising one or more reactive sites for the attachment of biomolecules, as well as biomolecules comprising one or more reactive sites for attachment to solid supports and polymer hydrogels. The invention further provides novel compositions and methods for the preparation of biomolecules, solid supports, and polymer hydrogels comprising reactive sites. The invention also provides for preparation of crosslinked solid supports, polymer hydrogels, and hydrogel arrays, wherein one or more biomolecules is attached by means of the reactive sites in a photocycloaddition reaction. Advantageously, according to the invention, crosslinking of the hydrogel and attachment of biomolecules can be done in a single step.

Abstract: A method of increasing the wet strength of a creped sheet, which method involves providing a sheet which includes cellulosic fibers, which sheet has a first side and a second side; applying a low temperature-curing latex adhesive binder composition to the first side of the sheet in a fine, spaced-apart pattern occupying from about 20 to about 50 percent of the surface area of the sheet; adhering the first side of the sheet to a creping surface; and creping the sheet from the creping surface. The binder composition is adapted to adhere the sheet to the creping surface and includes a functional group-containing latex, a functional group-reactive crosslinking agent, and a volatile base. In addition, the creping surface is heated at a temperature no greater than about 100° C.

Abstract: A medical packaging material based on a cellulosic nonwoven web which may be used in an oxidizing gas plasma sterilization environment. The material includes a cellulosic nonwoven web made up of fibers. From about 50 to 100 percent by weight of the fibers, based on the total weight of the fibers, are cellulosic fibers, and from 0 to about 50 percent by weight of the fibers, based on the total weight of the fibers, are noncellulosic fibers, such as glass wool and synthetic polymer fibers. In some embodiments, the cellulosic nonwoven web may be composed of 100 percent by weight of cellulosic fibers. The cellulosic nonwoven web includes a saturant which is present at a level of from about 50 to about 150 percent by weight, based on the dry weight of the fibers. The saturant includes a cellulosic fiber-protecting synthetic polymer having an effectively low permeability to hydrogen peroxide. For example, the cellulosic fiber-protecting synthetic polymer may have a water vapor transmission rate for a 2.

Abstract: A combined fill and relief valve is provided for a fluid chamber containing grease under pressure relative to surrounding atmosphere. The valve includes a housing having a longitudinal bore, the longitudinal bore including an inlet and an outlet. The housing also includes a transverse relief port in fluid communication with the atmosphere. A grease fitting is fixed to the housing against relative movement and is in fluid communication with the longitudinal bore. A fill valve assembly is fitted in the longitudinal bore and selectively permits flow therethrough from the inlet to the outlet. A relief valve assembly is fitted in the longitudinal bore and controls fluid passage between the outlet and the relief port.

Abstract: A fabric substrate comprising thermoplastic polyolefin fibers is printed with a printing composition comprising a room temperature curable latex polymer, a pigment and a cure promoter, which retains a colorfastness above 3 when exposed to liquids with a pH between about 2 and about 13. The mixture may be applied to the fabric as an aqueous mixture with a pre-cure pH adjusted to above 8 using a fugitive alkali and then cured at room temperature.